Evolution of the Average Target: Exelon Corporation

Evolution of the Target Price: Exelon Corporation

Changes in Analyst Recommendations: Exelon Corporation

ce9359bd1e89e.LO3islfg0BkjhT99bKVkufYDTE9Z3t0utE7zscCswCg.Xomm4G-PhntR1Gk0O5MV1oFHCwgPtLEX_zS04bfehXxfp5fqIaSFIGDdag~385b3962d3e41d2c0c078f47194a05ab
06-24 Morgan Stanley Adjusts Price Target on Exelon to $54 From $52, Maintains Equalweight Rating MT
05-21 Morgan Stanley Adjusts Price Target on Exelon to $52 From $55, Maintains Equalweight Rating MT
05-15 JPMorgan Adjusts Price Target on Exelon to $49 From $53, Maintains Neutral Rating MT
05-15 TD Cowen Adjusts Price Target on Exelon to $49 From $51, Maintains Hold Rating MT
05-13 KeyBanc Adjusts Price Target on Exelon to $41 From $43, Maintains Underweight Rating MT
05-11 Evercore ISI Adjusts Price Target on Exelon to $57 From $58 MT
04-28 Morgan Stanley Adjusts Price Target on Exelon to $55 From $56, Maintains Equalweight Rating MT
04-22 BMO Capital Adjusts Exelon Price Target to $48 From $49, Maintains Market Perform Rating MT
04-21 Morgan Stanley Adjusts Price Target on Exelon to $55 From $56, Maintains Equalweight Rating MT
04-21 KeyBanc Adjusts Price Target on Exelon to $43 From $44, Maintains Underweight Rating MT
04-20 Exelon Seen Offsetting PECO Rate Case Withdrawal Impact Over Time, RBC Says MT
04-20 Wells Fargo Adjusts Price Target on Exelon to $50 From $53, Maintains Overweight Rating MT
04-20 RBC Lowers Price Target on Exelon to $48 From $51, Keeps Sector Perform Rating MT
04-20 Jefferies Downgrades Exelon to Hold From Buy, Adjusts Price Target to $50 From $55 MT
04-17 Exelon Shares Fall After Multiple Downgrades MT
04-17 Mizuho Downgrades Exelon to Neutral From Outperform, Adjusts Price Target to $48 From $51 MT
04-17 Barclays Downgrades Exelon to Equalweight From Overweight, Adjusts PT to $49 From $50 MT
04-17 BMO Capital Downgrades Exelon to Market Perform From Outperform, Adjusts PT to $49 From $52 MT
04-17 Analyst recommendations: Albemarle, Newmont Corp, Texas Instruments, The Clorox Company, Oxy… Zonebourse
04-01 BMO Capital Adjusts Price Target on Exelon to $52 From $51, Maintains Outperform Rating MT
03-26 Argus Adjusts Price Target on Exelon to $52 From $48, Maintains Buy Rating MT
03-20 Morgan Stanley Adjusts Price Target on Exelon to $56 From $54, Maintains Equalweight Rating MT
03-12 JPMorgan Adjusts Price Target on Exelon to $53 From $48, Maintains Neutral Rating MT
03-05 Evercore ISI Adjusts Price Target on Exelon to $58 From $55, Maintains Outperform Rating MT
03-04 KeyBanc Adjusts Price Target on Exelon to $44 From $39, Maintains Underweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+4.31%
+15.93%
+12.01%
-7.85%
+1.17%
+4.09%
+7.52%
+36.44%
+4.38%
-0.08%
Average +7.79%
Weighted average by Cap. +8.67%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
47.40USD
Average target price
49.44USD
Spread / Average Target
+4.31%
High Price Target
58.00USD
Spread / Highest target
+22.36%
Low Price Target
41.00USD
Spread / Lowest Target
-13.50%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
JPMorgan Chase
TD Cowen
KeyBanc Capital Markets
Evercore ISI
BMO Capital
Wells Fargo Securities
RBC Capital Markets
Jefferies & Co.
Mizuho Securities
Barclays
Argus
UBS
Goldman Sachs
Scotiabank
Wolfe Research
BTIG
Guggenheim
BofA Securities
Seaport Global Securities
Credit Suisse
Vertical Research
Spin-Off Research
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
47.40USD
Average target price
49.44USD
Spread / Average Target
+4.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EXC Stock
  4. Consensus Exelon Corporation